Promethazine HCl Injection

Compare Promethazine HCl Injection  to:
Compare
Compare

Generic Name for Promethazine HCl Injection

Promethazine HCl 25mg/mL, 50mg/mL; sol for IM or IV inj; contains sulfites.

Legal Classification:

Rx

Pharmacological Class for Promethazine HCl Injection

Phenothiazine.

Manufacturer of Promethazine HCl Injection

Various generic manufacturers

Indications for Promethazine HCl Injection

For light sedation and relief of apprehension. Obstetric (during labor), pre- and post-operative sedation.

Adult dose for Promethazine HCl Injection

Sedation: 25–50mg IM or IV. Obstetric: 50mg IM or IV in early stages of labor; 25–75mg IM or IV when labor is established; may repeat once or twice at 4 hour intervals; max 100mg/day. Pre- and post-op: 25–50mg IM or IV.

Children's dosing for Promethazine HCl Injection

<2yrs: see Contraindications. ≥2yrs: should not exceed half that of suggested adult dose (see literature).

Contraindications for Promethazine HCl Injection

Children <2 years. Coma. Intra-arterial or subcutaneous injection.

Warnings/Precautions for Promethazine HCl Injection

Sulfite sensitivity. CNS depression. Impaired respiratory function (eg, COPD, sleep apnea). Narrow-angle glaucoma. GI or GU obstruction. Cardiovascular or liver disease. Seizure disorders. Peptic ulcer. Bone marrow depression. Elderly. Pregnancy (Cat.C). Labor & delivery. Nursing mothers: not recommended.

Interactions for Promethazine HCl Injection

Potentiates CNS depression with alcohol, other CNS depressants. Caution with epinephrine, anticholinergics, MAOIs. May alter hCG pregnancy test results and glucose tolerance tests.

Adverse Reactions for Promethazine HCl Injection

Inj site reactions, CNS depression/drowsiness, lowered seizure threshold, cholestatic jaundice, anticholinergic and extrapyramidal effects, neuroleptic malignant syndrome, photosensitivity, hypo- or hypertension, rash, blood dyscrasias, nausea, dry mouth, paradoxical reactions; children: respiratory depression (may be fatal).

How is Promethazine HCl Injection supplied?

Contact supplier.

Related Disease:

Insomnia

Related Resources

Silenor available for sleep maintenance insomnia

September 07, 2010

Somaxon announced that Silenor (doxepin tablets) has been made available for the treatment of insomnia characterized by difficulty with sleep maintenance.

FDA launches "Bad Ad Program" to detect misleading drug ads

May 11, 2010

The FDA's Division of Drug Marketing, Advertising, and Communications (DDMAC) has launched the Bad Ad Program, designed to educate healthcare providers about their role in ensuring that prescription drug advertising and promotion is truthful, and not misleading.

Silenor approved for insomnia

March 18, 2010

The FDA has approved Silenor (doxepin tablets, from Somaxon Pharmaceuticals) for the treatment of insomnia characterized by difficulty with sleep maintenance.

Exel/Exelint infusion set needles recalled

January 26, 2010

FDA notified healthcare professionals of a Class I recall of Exel/Exelint Huber needles, Exel/Exelint Huber Infusion Sets, and Exel/Exelint "Securetouch+" Safety Huber Infusion Sets due to 'coring,' the cutting or dislodging of silicone cores or slivers from the ports into which they are inserted).

McNeil Consumer Healthcare recalls certain over-the-counter (OTC) products

January 15, 2010

McNeil Consumer Healthcare and the FDA have announced a voluntary recall of certain lots of over-the-counter products, including Tylenol (acetaminophen), Motrin IB (ibuprofen), St. Joseph Aspirin (aspirin), Simply Sleep (diphenhydramine), and Rolaids (calcium carbonate and magnesium hydroxide).

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions